Onuma,fukushima, Japan
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Phase
3Span
209 weeksSponsor
Hoffmann-La RocheKishiwada
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
Phase
2Span
151 weeksSponsor
Incyte CorporationKishiwada
Recruiting
1-2 of 2